<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="87">
  <stage>Registered</stage>
  <submitdate>31/07/2005</submitdate>
  <approvaldate>5/08/2005</approvaldate>
  <actrnumber>ACTRN12605000082606</actrnumber>
  <trial_identification>
    <studytitle>INSTEP Trial</studytitle>
    <scientifictitle>Influence of NSAID on Short Term Efficacy of Pleurodesis for recurrent pneumothorax</scientifictitle>
    <utrn />
    <trialacronym>INSTEP</trialacronym>
    <secondaryid>Nil Known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Recurrent or persistent pneumothorax requiring VATS pleurodesis</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Other respiratory disorders / diseases</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Celebrex 200mg bd 5 days</interventions>
    <comparator>Placebo bd 5 days</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Rate of persistent air leak, pleural space problems or recurrent pneumothorax after VATS pleurodesis.</outcome>
      <timepoint>7 days</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Total analgesic usage. </outcome>
      <timepoint>7 days</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Drug-related complications. </outcome>
      <timepoint>30 days</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Late recurrence of pneumothorax.</outcome>
      <timepoint>2 years</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with surgical indication for pleurodesis due to recurrent or persistent pneumohtorax</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Chronic NSAID usage that cannot be stopped for more than 24 hours prior to surgery.
Renal impairment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Centrally held master list (hospital pharmacy)</concealment>
    <sequence>Computer generated, no stratification or blocking</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/10/2004</anticipatedstartdate>
    <actualstartdate>15/12/2004</actualstartdate>
    <anticipatedenddate>31/12/2018</anticipatedenddate>
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/12/2020</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>St Vincent's Hospital (Melbourne) Ltd - Fitzroy</hospital>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Gavin M Wright</primarysponsorname>
    <primarysponsoraddress>Cardiothoracic Research Office
St Vincent's Hospital (Melbourne)
41 Victoria Parade
Fitzroy VIC 3065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>University grant</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>For pain relief after VATS pleurodesis, patients are given either Celebrex or Placebo for 5 days plus any other required analgesics.  We aim to determine whether there is any difference in failure of the lung to adhere to the lining of the chest.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's Hospital, Melbourne</ethicname>
      <ethicaddress />
      <ethicapprovaldate>16/09/2016</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>St Vincent's and Mercy Private Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate>30/01/2006</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Gavin M Wright</name>
      <address>St Vincents's Hospital Melbourne
5th Floor
55 Victoria Parade
Fitzroy VIC 3065</address>
      <phone>+61 3 94192477</phone>
      <fax>+61 3 93171694</fax>
      <email>Gavin.Wright@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Jane Mack</name>
      <address>St Vincents's Hospital Melbourne
5th Floor
55 Victoria Parade
Fitzroy VIC 3065</address>
      <phone>+61 3 92884616</phone>
      <fax>+61 3 9288 4615</fax>
      <email>Jane.Mack@svha.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Gavin M Wright</name>
      <address>Cardiothoracic Research Office
4th Floor Inpatient Services Building
St Vincent's Hospital
41 Victoria Parade
Fitzroy VIC 3065</address>
      <phone>+61 3 9419 2477</phone>
      <fax />
      <email>Gavin.Wright@svha.org.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>